Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOtronik Study to Assess the CONTINUation of Existing Risk of Ventricular Arrhythmias After CRT-D Replacement for Patients With Primary Prevention Indication

NCT02323503 is registered in ClinicalTrials.gov with Biotronik SE & Co. KG as lead sponsor.

NCT NCT02323503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02323503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOtronik Study to Assess the CONTINUation of Existing Risk of Ventricular Arrhythmias After CRT-D Replacement for Patients With Primary Prevention Indication
Lead sponsor
Biotronik SE & Co. KG
Phase
Observational
Overall status
Completed
Start date
June 9, 2015
Completion date
February 12, 2020
Enrollment
289 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

biventricular pacemakers, artificial, cardiac resynchronization, cardioverter-defibrillators, implantable, device replacement